Free Trial
ASX:GMV

G Medical Innovations Holdings Ltd (GMV.AX) (GMV) Stock Price, News & Analysis

About G Medical Innovations Holdings Ltd (GMV.AX) Stock (ASX:GMV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
396,612 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

G Medical Innovations Holdings Ltd operates as a mobile health and e-health company. It develops and markets clinical and consumer medical-grade health monitoring solutions. The company develops Medical Smartphone Case, a solution that turns a phone into a mobile medical monitoring device; and G Medical Patch, a solution that provides continuous and real-time monitoring of a range of vital signs and biometrics. G Medical Innovations Holdings Ltd was founded in 2014 and is based in George Town, Cayman Islands.

Receive GMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for G Medical Innovations Holdings Ltd (GMV.AX) and its competitors with MarketBeat's FREE daily newsletter.

GMV Stock News Headlines

SBC Medical Group Holdings Incorporated (SBC)
Baird Medical Investment Holdings Ltd
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
ZKGCF ZKGC New Energy Limited
Alfabs Australia Limited (AAL.AX)
Momentum Metropolitan Holdings Ltd MTM
Trajan Group Holdings Limited (TRJ.AX)
See More Headlines

GMV Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that G Medical Innovations Holdings Ltd (GMV.AX) investors own include South32 (S32), Vaxxinity (VAXX), TherapeuticsMD (TXMD), Synthetic Biologics (SYN), Roblox (RBLX), Pear Therapeutics (PEAR) and UiPath (PATH).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
ASX:GMV
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.63 million
Price / Cash Flow
19.29
Book Value
A($0.01) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (ASX:GMV) was last updated on 6/5/2025 by MarketBeat.com Staff
From Our Partners